661 related articles for article (PubMed ID: 25689586)
1. APOE-modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective.
Tai LM; Ghura S; Koster KP; Liakaite V; Maienschein-Cline M; Kanabar P; Collins N; Ben-Aissa M; Lei AZ; Bahroos N; Green SJ; Hendrickson B; Van Eldik LJ; LaDu MJ
J Neurochem; 2015 May; 133(4):465-88. PubMed ID: 25689586
[TBL] [Abstract][Full Text] [Related]
2. A dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity.
Guo L; LaDu MJ; Van Eldik LJ
J Mol Neurosci; 2004; 23(3):205-12. PubMed ID: 15181248
[TBL] [Abstract][Full Text] [Related]
3. A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice.
Balu D; Valencia-Olvera AC; Nguyen A; Patnam M; York J; Peri F; Neumann F; LaDu MJ; Tai LM
Alzheimers Res Ther; 2023 Oct; 15(1):181. PubMed ID: 37858252
[TBL] [Abstract][Full Text] [Related]
4. The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer's Disease.
Kloske CM; Wilcock DM
Front Immunol; 2020; 11():754. PubMed ID: 32425941
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease.
Dorey E; Chang N; Liu QY; Yang Z; Zhang W
Neurosci Bull; 2014 Apr; 30(2):317-30. PubMed ID: 24652457
[TBL] [Abstract][Full Text] [Related]
6. Arabidopsis thaliana extracts optimized for polyphenols production as potential therapeutics for the APOE-modulated neuroinflammation characteristic of Alzheimer's disease in vitro.
Ghura S; Tai L; Zhao M; Collins N; Che CT; Warpeha KM; LaDu MJ
Sci Rep; 2016 Jul; 6():29364. PubMed ID: 27383500
[TBL] [Abstract][Full Text] [Related]
7. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice.
Kunzler J; Youmans KL; Yu C; Ladu MJ; Tai LM
Neurosci Lett; 2014 Feb; 560():131-6. PubMed ID: 24368217
[TBL] [Abstract][Full Text] [Related]
8. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
[TBL] [Abstract][Full Text] [Related]
9. ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function.
Manelli AM; Stine WB; Van Eldik LJ; LaDu MJ
J Mol Neurosci; 2004; 23(3):235-46. PubMed ID: 15181252
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
[TBL] [Abstract][Full Text] [Related]
11. Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo.
Tai LM; Koster KP; Luo J; Lee SH; Wang YT; Collins NC; Ben Aissa M; Thatcher GRJ; LaDu MJ
J Biol Chem; 2014 Oct; 289(44):30538-30555. PubMed ID: 25217640
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-mediated degradation of beta-amyloid via an apolipoprotein E isoform-dependent mechanism.
Zhao L; Lin S; Bales KR; Gelfanova V; Koger D; Delong C; Hale J; Liu F; Hunter JM; Paul SM
J Neurosci; 2009 Mar; 29(11):3603-12. PubMed ID: 19295164
[TBL] [Abstract][Full Text] [Related]
13. Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples.
Tai LM; Bilousova T; Jungbauer L; Roeske SK; Youmans KL; Yu C; Poon WW; Cornwell LB; Miller CA; Vinters HV; Van Eldik LJ; Fardo DW; Estus S; Bu G; Gylys KH; Ladu MJ
J Biol Chem; 2013 Feb; 288(8):5914-26. PubMed ID: 23293020
[TBL] [Abstract][Full Text] [Related]
14. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
[TBL] [Abstract][Full Text] [Related]
15. APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1.
Tachibana M; Holm ML; Liu CC; Shinohara M; Aikawa T; Oue H; Yamazaki Y; Martens YA; Murray ME; Sullivan PM; Weyer K; Glerup S; Dickson DW; Bu G; Kanekiyo T
J Clin Invest; 2019 Mar; 129(3):1272-1277. PubMed ID: 30741718
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E isoforms differentially regulate matrix metallopeptidase 9 function in Alzheimer's disease.
Ringland C; Schweig JE; Paris D; Shackleton B; Lynch CE; Eisenbaum M; Mullan M; Crawford F; Abdullah L; Bachmeier C
Neurobiol Aging; 2020 Nov; 95():56-68. PubMed ID: 32758917
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E Isoforms Differentially Regulate Alzheimer's Disease and Amyloid-β-Induced Inflammatory Response in vivo and in vitro.
Dorey E; Bamji-Mirza M; Najem D; Li Y; Liu H; Callaghan D; Walker D; Lue LF; Stanimirovic D; Zhang W
J Alzheimers Dis; 2017; 57(4):1265-1279. PubMed ID: 28372324
[TBL] [Abstract][Full Text] [Related]
18. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
Keeney JT; Ibrahimi S; Zhao L
J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
[TBL] [Abstract][Full Text] [Related]
19. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E isoform-dependent effects on the processing of Alzheimer's amyloid-β.
Chai AB; Lam HHJ; Kockx M; Gelissen IC
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Sep; 1866(9):158980. PubMed ID: 34044125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]